Several Zimbabweans living with HIV say they are eagerly waiting for an opportunity to take the recently approved and groundbreaking Cabotegravir shot, an injectable prevention drug that curbs the contraction of the life-threatening virus. For more, VOA’s Columbus Mavhunga spoke to health authorities and persons living with HIV.